Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cystoscopic REDuction In BLadder Evaluations for Microhematuria - A Prospective Randomized, Controlled, Clinical Utility Study for Evaluation of Microhematuria (The CREDIBLE Study)

NCT06394869 is registered in ClinicalTrials.gov with Pacific Edge Limited as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06394869 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cystoscopic REDuction In BLadder Evaluations for Microhematuria - A Prospective Randomized, Controlled, Clinical Utility Study for Evaluation of Microhematuria (The CREDIBLE Study)
Lead sponsor
Pacific Edge Limited
Phase
Not applicable
Overall status
Recruiting
Start date
April 29, 2025
Completion date
April 30, 2028
Enrollment
1,000 (estimated)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

hematuria - cause not known